chr14-23415801-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP2PP3_Strong
The ENST00000355349.4(MYH7):c.4985G>C(p.Arg1662Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1662H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000355349.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.4985G>C | p.Arg1662Pro | missense_variant | 35/40 | ENST00000355349.4 | NP_000248.2 | |
MHRT | NR_126491.1 | n.233C>G | non_coding_transcript_exon_variant | 2/6 | ||||
MYH7 | NM_001407004.1 | c.4985G>C | p.Arg1662Pro | missense_variant | 34/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.4985G>C | p.Arg1662Pro | missense_variant | 35/40 | 1 | NM_000257.4 | ENSP00000347507 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
MYH7-related skeletal myopathy Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Neurogenetics Laboratory, Royal Perth Hospital | Jan 01, 2013 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Oct 06, 2023 | This missense variant replaces arginine with proline at codon 1662 of the MYH7 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in a two unrelated families affected with Laing distal myopathy (PMID: 33298082 and 24664454). This variant has not been reported in individuals with MYH7-related cardiovascular disorders. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
MYH7-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 27, 2021 | The MYH7 c.4985G>C (p.Arg1662Pro) variant is a missense variant. This variant was first reported by Lamont et al. (2014) in an Italian family with Laing distal myopathy, though it is unclear how many affected family members carried the variant. Yu et al. (2020) also identified the variant in a Chinese family with Laing distal myopathy, where the variant segregated with disease in the affected mother and daughter. This variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database despite its location in a region of good sequencing coverage, which suggests the variant is rare. Based on the available evidence, the p.Arg1662Pro variant is classified as a variant of uncertain significance for Laing distal myopathy. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at